Lia Gore is an Oncology physician affiliated with Children's Hospital Colorado. OpenAlex indexes 355 publications with 11,178 citations (h-index 57); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13123 E 16th Ave
Aurora, CO 800457106
Telephone
720-777-1234Registry record last updated 5 Oct 2012.
Clinical trials
- Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Sponsor: Amgen Research (Munich) GmbH
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918
Sponsor: AstraZeneca
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202516 payments$39,906openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year20241 payment
- JAZZ PHARMACEUTICALS INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2005–2015 per NIH RePORTER. The latest:
- 17-AAG IN PEDIATRIC PATIENTS WITH RECURRENT/REFRACTORY MALIGNANCIES
University of Colorado Denver
FY2007$370M01RR000069 - 17-AAG IN PEDIATRIC PATIENTS WITH RECURRENT/REFRACTORY MALIGNANCIES
University of Colorado Denver
FY2006$1,486M01RR000069
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
New England Journal of Medicine
2024 - Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma
European Journal of Cancer
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Glenn Furuta, MD
Children's Hospital Colorado
Samuel Dominguez, MD
Children's Hospital Colorado
Michael Narkewicz, MD
Children's Hospital Colorado
Robin Deterding, MD
Children's Hospital Colorado
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”